| Issue Date | Title | Author(s) |
| 1 | 2015 | Antiproliferative and apoptotic effects of ponatinib and its effects on macromolecular changes in imatinib-sensitive and resistant chronic myeloid leukemia (CML) cell lines: a mechanistic approach | Kartal Yandım, Melis; Ceylan, Çağatay ; Elmas, Efe; Baran, Yusuf |
| 2 | 2015 | Discovering alternative targets in chronic myeloid leukemia (CML): determination of expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant CML patients | Kartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali; Baran, Yusuf |
| 3 | 2015 | Effects of placental derived mesenchymal stem cells on experimental asthma | Sözmen, Çağlayan S.; Karaman, M.; Baran, Yusuf ; Micili, Cilaker S.; Kartal Yandım, Melis; Kiraz, Yağmur ; Karaman, O. |
| 4 | Sep-2015 | Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted “hsa-miR-2278” as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A | Tezcanlı Kaymaz, Burçin; Selvi Günel, Nur; Ceyhan, Metin; Bozok Çetintaş, Vildan; Özel, Buket; Kartal Yandım, Melis; Kıpçak, Sezgi; Aktan, Çağdaş; Adan Gökbulut, Aysun ; Baran, Yusuf ; Kosova Can, Buket |
| 5 | Mar-2015 | Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line | Tüfekçi, Özlem; Kartal Yandım, Melis; Ören, Hale; İrken, Gülersu; Baran, Yusuf |
